By: Justin Morgenstern
A critical appraisal of the ANDROMEDA-SHOCK-2 trial: difficult to interpret because of the subjective composite outcome
Justin Morgenstern is a Senior Research Associate at First10EM. He focuses on themes related to medicine and healthcare, particularly in the areas of healthcare administration, patient care, public health, and wellness. Justin's insights and expertise have been featured in First10EM.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston


Not enough data
Justin Morgenstern's coverage heavily focuses on scientific and healthcare topics, with a strong emphasis on medical research and emergency medicine. His articles often cite data, indicating a preference for evidence-based content.
If you are looking to reach out to Justin, consider offering pitches that provide in-depth analysis of medical research studies or developments in the field of emergency medicine. Ensure that your pitch is supported by credible data and aligns with evidence-based practices.
Given his focus on diagnostic imaging, pregnancy-related topics, medication use, and ethical considerations within emergency departments, sources with expertise in these areas may find success in reaching out to him for potential collaboration.
This information evolves through artificial intelligence and human feedback. Improve this profile .